What do cutting-edge medical treatments, microscopic data storage

devices, advanced plastics, hydrogen fuel cells, and a new nose have
in common?
They are all constructed from tiny molecular
components called macrocycles… Like
stone in the Stone Age, bronze in the
Bronze Age, and iron in the Iron Age,
macrocycles are the building blocks of the
21st century – the Molecular Age

Chlorophyll (seen above) is a

naturally occurring macrocycle
 About ODIN Industries
ODIN Industries is a molecular engineering company specialized in
macrocycle compound R&D, technology assessment, new product pipeline
development, and manufacturing. The company’s proprietary technology
gives individuals, institutions and companies the ability to exploit vast,
undeveloped chemical space, establish strong patent protection, and deliver
big profit margins on innovative new products that, until now, have had
little or no commercial viability. Through internal and external programs,
licensing, and partnerships, ODIN is working to drive the discovery and
development of pharmaceuticals, advanced materials, fuel cells,
anticorrosives, CO2 sequestration technologies, water purification, and
other important technologies that use macrocycles as key components.
 Growing Your Company

There aren’t many ways to double or triple

a company’s revenue…
…and cutting jobs doesn’t grow the company
Your Company Can…
build a new pipeline with internal R&D

But this is
- slow (5-10 years),
- expensive,
- risky, and
-likely to afford ”me too products” due to the
need to be first to market
 Your Company Can…
acquire existing companies and/or technologies

But this is
- expensive,
- competitive, and
- risky (why is company/technology available?)
or Your Company Can Build…

better, faster, cheaper!

 E = MC2
The Laboratory to Market Dilemma
provides an opportunity for real growth with “first in class” products

Individuals, companies, academic institutions, and

research organizations have discovered countless new
products and technologies that are ready to be
developed, but are too expensive to move through the
pipeline with current research, development and
manufacturing methods.
 $$$$
Translation

There exist thousands of under-valued third-party

products and technologies that could benefit
Your Company’s pipeline.
So How Big Is This Opportunity?
 From Lab to Life
ODIN Industries has developed and patented a
revolutionary new platform technology for the
development and manufacture of a highly sought-after
component called the macrocycle.

Though ODIN’s technology is a “leap-frog” technology

that overcomes the obstacles faced in the development
and commercial exploitation of these extraordinary
components, the timing of this breakthrough has created
a very unique opportunity for Your Company - one that
occurs very rarely in history.
 Set Your Own Rhythm

Unlike most innovations that have a particular rhythm

as the new technology is born, develops, matures, and
then balloons, ODIN’s technology provides a platform
to bring an immense back-log of products from the
laboratory to life. Instead of having to wait for
products to evolve from ODIN’s technology, market-
ready proto-types will flow rapidly through the
pipeline with the aid of ODIN’s technology.
ODIN’s patented platform technology, called
Dynamic Oligomer Control Cyclization or DOCC,
enables the manufacture of highly sought-after
components that are essential to the development of
cutting edge products from more than eight (8)
diverse industries. Market-ready proto-types, which
currently teeter on the edge of success, can now be
rapidly moved from the laboratory to the market.

Exciting new products ranging from

pharmaceuticals to synthetic fuels; photovoltaic
devices to advanced plastics; and hydrogen fuel cells
to clean water; will quickly emerge with ODIN’s
macrocycles inside.
 “ODIN Inside” green
chemistry

water
purification biosensors

soaps
solar
additives lubricants
energy
detergents

anticorrosive CO2 medical fuel

paint sequestration devices cells

clean aerospace dyes

defense bio-tech
coal

first in class disease synthetic flavors &

plastics healthcare
drug leads detection rubber fragrances

DOCC
With much more to come !
Just Added

Oil bio-remediation
Doors That Open Toward
New Beginnings
 Just A Few Non-Trivial Markets

Solar Energy, Automotive, Aerospace, Defense,

Synthetic Rubber, Plastics, Nanotechnology, CO2 Sequestration,
Fuel Cells, Batteries, Water Purification, Anti-Corrosives, Crop Science,
Pest control, Animal Health
 Water Purification
Specialty chemicals for water treatment - $22 billion globally

• PPM-PPT metal sequestration

– monitoring, concentrating, removing, recovery
– reversible
– non-reversible

• Disinfection/Photodynamic effect
– microbes

• Bleaching

• Destruction of organics

• Oil spill bio-remediation

 Healthcare

• Antimicrobials • Biomaterials
– for textiles
• bedding • Biosensors
• bandages etc. – Medical
– for hard surfaces – Agricultural
– Environmental
• Antibacterials for hard surfaces – Industrial
 Automotive/Transportation

• Corrosion Protection ($100 billion) • Lubricants

– High Ox/Red
– Non-Toxic • Anti-icing
– Primer & Pigment coats
• Self-Cleaning Glass
• Fuel Cells
• Advanced materials
• Batteries
• Recyclable materials
• Synthetic Rubber
 Macrocycle-Based Plastics
50 billion pounds plus annually
• Low Viscosity
– Fewer imperfections
– Lower processing temperatures
• No Out-Gassing
– Fewer imperfections
– Less toxic Consumer Products
– Greener
• More Advanced Products (Hyper Car Project)
– Lighter than steel
– More Impact Resistant than Steel
• Recyclable
 Macrocyclic Plastics
These macrocycle-based plastics have many advanced properties, and
could replace traditional plastics (more than a 50 billion pound/year
industry). In addition, macrocycle-based plastics can be used to replace
many heavier steel components in, for example, the aerospace and
transportation industries. These plastics have been highly sought after
by major companies, including Ford and GE, for over two decades
because they have the strength of conventional metals, but are 30%
lighter (thus reducing fuel costs), and they are 30% - 60% more impact
resistant so safety is increased dramatically. Unfortunately, the cost of
manufacturing is still 2 to 5 times higher than more traditional
materials, thus most companies are not willing to adopt them at this
price.
 Soaps, Detergents, Surfactants

• Non-peroxide bleaching catalysts

– textiles (better bleaching, less dye damage)
– wood pulp

• Detergents with antiviral, hemolytic, and antibacterial activities

• Anti-static agents
Food & Beverages

• Flavors & Fragrances

• Food preservatives

• Sensing for contamination

• Tasting [in color]

Macrocycle-Based Solar Cells
 Solar Energy
Most silicon-based solar cells are very inefficient, typically
around 10%. Although some improvement can be anticipated,
the fundamental problem is that silicon-based systems do not
absorb much light. Macrocycle-based solar cells, on the other
hand, are designed using natures own light-absorbing
technology, chlorophyll. Furthermore, macrocycles can be
incorporated into other materials such as plastics for ease of
use, and application. Unfortunately, while these macrocyclic
systems are certainly the future of the solar energy industry,
without ODIN’s technology they will remain much too
expensive to produce on a commercial scale, and will not come
online for many years into the future.
Fueling the Future
fuel cells and batteries
 Fuel Cells & Batteries

A green automotive industry and a green economy will

succeed or fail with the development of ways to store
energy. Fuel cells and batteries are not only necessary for
running our green automobiles, they are necessary for
storing both wind and solar energy for times when the
wind is not blowing and the sun is not shining.
Macrocycle-based technologies show great promise in
both of these areas, but the cost of these products will
keep them out of the hands of the consumer.
 Peptide Antibiotics

These drugs are used to treat MRSA, C. difficile, and other

high profile superbugs. However, they are very difficult to
make, and it is virtually impossible to make analogs
(relatives of the original drug), which are important once
bacteria become resistant to the original drug. It is for this
reason that it has been more than twenty years since the last
new antibiotic was introduced, and the reason that most
major pharmaceutical companies have abandoned the
antibiotic business.
 New Light on Medicine
Photodynamic Therapy (PDT)
Laser Light
Killer Oxygen

Macrocycle

Super-Charged Macrocycle-Oxygen complex

Tumor cell death

 Macrocyclic PDT Drugs

Photodynamic therapy (PDT) is a bimodal treatment for cancer (and other

diseases), which has few side effects. Unfortunately, the clinical
performance of this treatment has not lived up to expectations. This is due
to the fact that the macrocyclic drugs used in PDT are isolated from nature
as impure substances, and can not be optimized for efficacy. Second and
third generation synthetic macrocycles perform much better than their
natural counterparts, but they are too expensive to use. Unfortunately,
companies that have pioneered this area are now going out of business and
there is a risk that this technology will be abandoned.
Synthetic Rubber from Macrocycles

In yet another emerging crisis, the world-wide

demand for natural rubber will outpace the supply
in less than 5 years, so research on synthetic
rubbers is at a frantic pace. Some synthetic rubbers
are currently being used on high-end performance
and race cars, but the cost is still too high for mass
development and commercialization.
 Drugs from the Sea
Supply is a serious obstacle to the development of many
promising marine-based therapies. The concentrations of
many highly active compounds in marine invertebrates are
often minute, sometimes accounting for less than 0.1 % of
the wet weight. If one of these compounds were to make it
to the market the annual need for a single compound is
estimated to be roughly 3,000–16,000 metric tons of
biomass per year. It is obvious that such a large amount of
biomass, consisting of either sponges, tunicates or other
pharmacologically promising marine invertebrates, can
never be harvested without risking extinction. Synthetic
strategies for environmentally sound and economically
feasible supplies of marine natural products are therefore
needed.
 The Bottom Line

ODIN’s technology makes cutting-edge science and

technology commercially viable now, and accelerates research
in emerging industries that would not otherwise be viable for
many years into the future.
But How Can A Process
Grow Our Business?
 An Ordinary Day’s Work…

1000 assembled Model T chassis

Now imagine if this process did not just apply to one product,
but thousands of new and innovative products!
ODIN’S INTELLECTUAL PROPERTY POSITION
ODIN controls proprietary technology relating to the synthesis of macrocyclic compounds and
compounds (“ODIN Technology") that is the subject of U.S. Patent Application No. 11/059,796
and many other international applications filed February 17, 2005 in the names of Thomas
Johnson and Billy Fowler for “Methods, Compositions, and Apparatuses for Forming Macrocyclic
Compounds”. Based on a review of the technology incident to patent filing by Intellectual
Property Technology Law (IPTL), Research Triangle Park, NC, AND by the United States Patent
& Trade Office ODIN’s intellectual property is a novel and fundamental enabling technology for
the manufacture of macrocyclic compounds. The technology resolves a number of basic problems
that have limited the prior commercial synthesis of macrocyclic compounds to small yield and
small-volume production involving costly and complex purification procedures. By enabling high
yields of macrocyclic compounds to be economically achieved at high volume, the technology
makes these compounds widely available at low costs.

UPDATE 05/04/2010: The first of ODIN’s patents have issued in the

United States, Singapore, and Mexico. Many other applications are
patent pending and are expected to issue over the next year.
Technology, Vision & Timing

Pharmaceuticals

Specialty Biotechnology
Chemicals
Industrial
Chemicals ODIN LifeSciences

Advanced Renewable
Materials Energy

Nanotechnology